Jupiter Life Line Hospitals JLHL Trading Window Closure
NiveshIQ
NSE: JLHL · Healthcare
Jupiter Life Line Hospitals Ltd.
₹247.10▼ ₹2.90 (-1.16%)
Price Chart · Daily closes
1Y
6M
3M
1M
1W
1D
⚡ Intelligence Signals
5 active
🟢 Bullish Earnings Catalyst
📊 RS Laggard (5D)
🔄 Sector Sweep
⚡ Signals Aligned
📉 Pullback
NiveshIQ has detected 5 active signals on JLHL. Sign up free to see what each signal means and how it affects the stock.
Unlock signals — freeExpected Move
1D / 1W / 1M range derived from news, fundamentals & technicals
1 Day
±1.8%
1 Week
±4.2%
1 Month
±9.6%
Confidence Score
Based on historical directional & magnitude accuracy for this stock
74
/ 100
About Jupiter Life Line Hospitals Ltd.
Jupiter Life Line Hospitals Limited (JLHL) operates a network of multi‑specialty hospitals under the Jupiter brand, offering a broad spectrum of services including bariatric surgery, cardiac and neurosurgery, oncology, robotic procedures, and a dedicated hotel under the Fortune Park Lake City brand. The company’s revenue for FY27 stood at ₹1,558 crore, driven primarily by high‑margin specialty surgeries and expanding outpatient services across its 20+ locations. Recent Q2 FY27 data preview indicates a 12% YoY increase in operating income, reflecting higher patient volumes and improved cost controls. JLHL maintains a competitive edge through advanced technology adoption, such as robotic knee replacement and TAVI/TAVR, and a strong referral network in Tier‑I and Tier‑II cities. The firm’s ma
Financial Highlights
| Metric | FY24 | FY25 | FY26 |
|---|---|---|---|
| Revenue | ₹1,070 Cr +19.80% | ₹1,262 Cr +17.96% | ₹1,500 Cr +18.88% |
| EBITDA Margin | 22.27% | 23.51% | 22.89% |
| Net Profit | ₹176.61 Cr +142.20% | ₹193.20 Cr +9.39% | ₹194.41 Cr +0.63% |
| EPS | ₹28.65 | ₹29.47 | ₹29.59 |
Annual figures in Indian Rupees (Crores). Source: company filings (NSE).
Recent News
Jupiter Life Line Hospitals JLHL Trading Window Closure
Jupiter Hospitals Q2 FY27 Data Preview
🔒
+ 3 more stories about Jupiter Life Line Hospitals Ltd.
Full news feed with AI impact summaries, synced in real time.
Sign up free — it's instantStrategic Outlook
- Q2FY27 results: revenue ₹456 Cr, PAT ₹56 Cr, EPS ₹1.72, EBITDA margin 23.4%. Growth context: revenue YoY +16.0%, PAT YoY -2.1%, revenue QoQ +11.1%, PAT QoQ +49.8%.
Management commentary points to R&D investments and technology initiatives as the primary near-term growth lever, with e...
FY26 (last completed FY): revenue ₹1, 500 Cr, PAT ₹194 Cr, EBITDA margin 22.9%, EPS ₹29.59. Year-on-year: revenue YoY +1...
🔒
+ 3 more outlook points
Growth drivers, key risks, and upcoming catalysts — unlocked free.
Sign up free — it's instantMore Healthcare stocks
Everything you unlock with a free account
⚡Intelligence Signals — AI-detected patterns across news, earnings & technicals
📈Price Chart — 1D to 1Y daily closes for JLHL
🎯Expected Move — 1D / 1W / 1M range from news, fundamentals & technicals
🧠Confidence Score — Historical directional & magnitude accuracy for this stock
🎙Analyst Target Price — Consensus target with buy / hold / sell breakdown
📰Full News Feed — All stories synced in real time with AI impact summaries
🔭Strategic Outlook — Growth drivers, risks & upcoming catalysts
📊Watchlist & Portfolio — Track JLHL alongside your other holdings
Unlock full JLHL research — free
No credit card · No trial · Always free to start
Frequently Asked Questions
What AI signals does NiveshIQ provide for Jupiter Life Line Hospitals Ltd.?
NiveshIQ detects active intelligence signals for Jupiter Life Line Hospitals Ltd. (JLHL) — including earnings catalysts, relative strength patterns, sector sweeps, and pullback setups. It also shows an Expected Move (1D/1W/1M range based on news, fundamentals and technicals) and a Confidence Score based on historical directional and magnitude accuracy. These are exclusive to NiveshIQ.
What are the key financials for Jupiter Life Line Hospitals Ltd.?
Jupiter Life Line Hospitals Ltd. operates in the Healthcare sector with a market capitalisation of ₹820,231.0L Cr. Revenue, net profit, EPS and EBITDA margins across the last three annual periods are shown above, sourced from BSE filings.
Does NiveshIQ provide investment advice?
No. NiveshIQ provides educational market intelligence and research context, not investment advice or buy/sell recommendations.